Category: News

Researchers from the IMI ConcePTION project have published an analysis investigating the ability of pregnancy pharmacovigilance data sources to map their datasets to the CDE recommendations framework. More information is available here. Photo by Mikhail Fesenko on Unsplash

Researchers from TIS Berlin have led an international collaborative ENTIS study investigating previously reported safety signals of increased risks for major congenital anomalies and impaired fetal growth following maternal modafinil use in pregnancy. Further information is available here. Photo by Gregory Pappas on Unsplash

Researchers from the University of California San Francisco have published population-based cohort study using data collected from the Kaiser Permanente Northern California insurance database which has investigated the risk of adverse neonatal outcomes following maternal cannabis use in pregnancy. More information is available here. Photo by Thought Catalog on Unsplash

Researchers from the Netherlands Pharmacovigilance Centre Lareb, including several ENTIS members, have published a study comparing infants’ birth defects as reported by mothers and general practitioners. More information is available here. Photo by CDC on Unsplash

Researchers from the MONEAD investigator group have published the results of a longitudinal study investigating associations between fetal anti-seizure medication (ASM) exposure and adaptive, behavioural or emotional, and neurodevelopmental disorder outcomes at 2, 3, and 4.5 years of age. More information is available here.

ENTIS members from the Berlin TIS (Embryotox) have published a comparative cohort study investigating pregnancy outcomes for pregnancies exposed to levetiracetam. More information can be found here.

Researchers affiliated with the Pregnancy Inflammatory bowel disease And Neonatal Outcomes (PIANO) registry have published a study of pregnancy and infant outcomes following maternal vedolizumab and ustekinumab use in pregnancy. More information can be found here.

Researchers affiliated to The AVONEX® Pregnancy Exposure Registry (Biogen) have published a case series of 306 pregnancy outcomes for a cohort of women with multiple sclerosis who used intramuscular interferon beta-1a during the first trimester. More information available here. Photo by Mufid Majnun on Unsplash

In 2022, the European Society for Medical Oncology held a virtual meeting to gain insights from a multidisciplinary group of experts and develop statements about the management of breast cancer during pregnancy. The recommendations are available here. Photo by Anastasiia Chepinska on Unsplash